Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Publication date: 1 January 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 94, Issue 1
Author(s): W.U. Shipley, W. Seiferheld, H. Lukka, P. Major, N.M. Heney, D. Grignon, O. Sartor, M. Patel, J.P. Bahary, A.L. Zietman, T.M. Pisansky, K.L. Zeitzer, C.A.F. Lawton, F.Y. Feng, R.D. Lovett, A. Balogh, L. Souhami, S.A. Rosenthal, K.J. Kerlin, H.M. Sandler




from Cancer via ola Kala on Inoreader http://ift.tt/1Z5LILO
via IFTTT